sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology
The Vanguard Group, Inc. has filed a Form 8.3, revealing its interests and dealings in the securities of Mural Oncology plc. As stipulated by the Irish Takeover Panel under Rule 8.3, the disclosure documents The Vanguard Group’s position in the company as of 14 August 2025.
The filing shows that The Vanguard Group owns and controls 771,827 ordinary shares of Mural Oncology, representing 4.47% of the company's relevant securities. The disclosure does not include any cash-settled or stock-settled derivatives beyond the owned shares.
Additionally, 64 ordinary shares were sold at a price of 1.77 USD per share. No other dealings, derivative transactions, or option agreements were disclosed. The document affirms there are no indemnities or option arrangements related to their position.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.